ChemicalBook English  Japanese  Germany

(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE

CAS号:158342-64-4
英文名称:(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE
英文同义词:(3S,10R,13S,14S,16R)-16-BroMo-3-hydroxy-10,13-diMethyl-3,4,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one;(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE
中文名称:
中文同义词:
CBNumber:CB9663066
分子式:C19H27BrO2
分子量:367.32048
MOL File:158342-64-4.mol
(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE化学性质
安全信息

(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE 性质、用途与生产工艺

(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE 上下游产品信息
上游原料
下游产品
(3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE 生产厂家      全球有 1家供应商        (3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE国内生产厂家
供应商联系电话传真电子邮件国家产品数优势度
南京诺利斯医药科技有限公司 +86-25-66112881 +86-25-66112885+86-25-52131256sales@norris-pharm.com中国 9787 55
 
158342-64-4, (3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE 相关搜索:
158342-64-4 (3S,10R,13S,14S,16R)-16-BroMo-3-hydroxy-10,13-diMethyl-3,4,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one (3S,10R,13S,14S,16R)-16-BROMO-3-HYDROXY-10,13-DIMETHYL-3,4,7,8,9,10,11,12,13,14,15,16-DODECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17(2H)-ONE
Copyright 2016 © ChemicalBook. All rights reserved